VitaNova Life Sciences (YJGJ) Long-Term Debt Issuances (2018 - 2025)
VitaNova Life Sciences (YJGJ) has disclosed Long-Term Debt Issuances for 7 consecutive years, with -$26000.0 as the latest value for Q1 2025.
- For the quarter ending Q1 2025, Long-Term Debt Issuances fell 1496.35% year-over-year to -$26000.0, compared with a TTM value of $46400.0 through Oct 2025, down 54.83%, and an annual FY2024 reading of $3137.0, down 21.58% over the prior year.
- Long-Term Debt Issuances was -$26000.0 for Q1 2025 at VitaNova Life Sciences, down from $72400.0 in the prior quarter.
- Across five years, Long-Term Debt Issuances topped out at $72400.0 in Q4 2024 and bottomed at -$26000.0 in Q1 2025.
- Average Long-Term Debt Issuances over 4 years is $12444.9, with a median of $6942.0 recorded in 2021.
- The sharpest move saw Long-Term Debt Issuances surged 38294.16% in 2024, then crashed 1496.35% in 2025.
- Year by year, Long-Term Debt Issuances stood at $12100.0 in 2021, then skyrocketed by 108.87% to $25273.0 in 2023, then skyrocketed by 186.47% to $72400.0 in 2024, then tumbled by 135.91% to -$26000.0 in 2025.
- Business Quant data shows Long-Term Debt Issuances for YJGJ at -$26000.0 in Q1 2025, $72400.0 in Q4 2024, and $52600.0 in Q3 2024.